WHO says investigators conclude Ebola victim did not enter Rwanda
GENEVA (Reuters) – A Congolese woman who may have spread the deadly Ebola virus in Uganda did not go to Rwanda or the Congolese city of Goma while contagious, the…
Timeline: How a Congo Ebola outbreak became a global concern
DAKAR (Reuters) – The World Health Organization has declared Congo’s Ebola outbreak an international health emergency, after the virus threatened to spread to a major city and into neighboring countries.…
WHO sounds Ebola alarm as risks intensify
GENEVA (Reuters) – The World Health Organization on Wednesday declared Congo’s Ebola outbreak an international health emergency, sounding a rarely used global alarm after the virus threatened to spread to…
WHO flags Ebola risk in Rwanda, but then withdraws its report
GENEVA (Reuters) – The World Health Organization on Thursday withdrew a report that said an Ebola patient may have entered Rwanda, suggesting the deadly virus could spread to that country…
Facebook vows Libra currency will wait for approval as U.S. airs worries
WASHINGTON (Reuters) – Facebook Inc said on Monday it would not proceed with the launch of its Libra cryptocurrency until regulatory concerns are addressed, as the U.S. Treasury secretary took…
Ebola spread to east Congo’s Goma massively raises risk – U.N.
GOMA, Democratic Republic of Congo/GENEVA (Reuters) – Ebola’s arrival in eastern Congo’s main city of Goma severely raises the risk of the virus spreading if it takes root in this…
AB InBev pulls Budweiser listing, canceling year’s largest IPO
HONG KONG/NEW YORK/BRUSSELS (Reuters) – Anheuser-Busch InBev said on Friday it will not proceed with the planned listing in Hong Kong of its Asia Pacific unit, Budweiser Brewing Company APAC…
Potential IPO candidate BioNTech secures $325 million in financing round
FRANKFURT (Reuters) – German biotech firm BioNTech has secured $325 million in a private financing round to boost its cancer immunotherapies pipeline, the company said on Tuesday. Two-thirds of the…
Novartis to sell epinephrine shot in U.S. pharmacies amid EpiPen shortage
(Reuters) – Novartis AG (NOVN.S) said on Tuesday it would make its generic pre-filled epinephrine shots immediately available in local pharmacies across the United States, as a shortage of Mylan…
Novartis to sell epinephrine injector in U.S. pharmacies amid EpiPen shortage
FILE PHOTO: EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. REUTERS/Jim Bourg/File Photo (Reuters)…